Financial results - AMBROSIA BIOSCIENCE SRL

Financial Summary - Ambrosia Bioscience Srl
Unique identification code: 15964950
Registration number: J12/3445/2003
Nace: 2120
Sales - Ron
415.464
Net Profit - Ron
104.102
Employees
2
Open Account
Company Ambrosia Bioscience Srl with Fiscal Code 15964950 recorded a turnover of 2024 of 415.464, with a net profit of 104.102 and having an average number of employees of 2. The company operates in the field of Fabricarea preparatelor farmaceutice having the NACE code 2120.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Ambrosia Bioscience Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 352.471 375.645 379.942 368.256 417.401 279.189 345.558 395.196 386.441 415.464
Total Income - EUR 680.259 591.068 375.619 366.648 463.964 250.290 391.842 360.876 352.721 418.879
Total Expenses - EUR 572.162 482.843 258.358 265.573 353.789 180.040 279.486 235.941 250.676 302.527
Gross Profit/Loss - EUR 108.097 108.225 117.261 101.075 110.175 70.250 112.356 124.935 102.044 116.351
Net Profit/Loss - EUR 90.251 93.661 112.847 96.407 106.001 67.639 109.327 121.830 99.405 104.102
Employees 4 4 4 4 4 3 3 3 3 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 8.1%, from 386.441 euro in the year 2023, to 415.464 euro in 2024. The Net Profit increased by 5.253 euro, from 99.405 euro in 2023, to 104.102 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Ambrosia Bioscience Srl

Rating financiar

Financial Rating -
AMBROSIA BIOSCIENCE SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Ambrosia Bioscience Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ambrosia Bioscience Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Ambrosia Bioscience Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ambrosia Bioscience Srl - CUI 15964950

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 198.926 3.922 48.282 31.853 17.365 3.685 3.704 3.512 6.109 28.392
Current Assets 510.749 266.058 252.753 240.043 262.791 227.915 267.320 332.520 322.971 306.362
Inventories 31.649 31.688 107.948 78.828 71.045 50.898 88.368 55.316 85.410 38.389
Receivables 164.432 165.414 68.720 60.673 174.584 62.828 70.697 225.458 151.473 219.536
Cash 314.669 68.955 76.085 100.542 17.162 114.190 108.255 51.746 86.088 48.437
Shareholders Funds 680.695 93.928 113.110 207.441 106.253 113.467 144.045 122.074 130.406 104.344
Social Capital 225 223 219 215 211 207 202 203 202 201
Debts 29.619 176.653 187.925 64.455 173.903 118.133 126.979 213.958 198.674 230.411
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "2120 - 2120"
CAEN Financial Year 2120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 306.362 euro in 2024 which includes Inventories of 38.389 euro, Receivables of 219.536 euro and cash availability of 48.437 euro.
The company's Equity was valued at 104.344 euro, while total Liabilities amounted to 230.411 euro. Equity decreased by -25.334 euro, from 130.406 euro in 2023, to 104.344 in 2024.

Risk Reports Prices

Reviews - Ambrosia Bioscience Srl

Comments - Ambrosia Bioscience Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.